Healthcare Analysts discuss what wet AMD patients want (relevant companies CLSD, OCUL, EYPT, REGN, OPT, OTLK, ADVM, FDMT, RGNX, ABBV) on an Analyst/Industry conference call to be held on September 18.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLSD:
- Clearside completes final participant visit in CLS-AX trial for wet AMD
- Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
- Clearside Biomedical management to meet with Oppenheimer
- Clearside Biomedical initiated with a Buy at Chardan
- Clearside Biomedical reports Q2 EPS (10c), consensus (13c)